-
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices— After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints --Zuckerberg cash helping to propel Chicago's biotech ambitions -- See more on our front page newsDismiss Notice
Why Amgen Is Up More Than 6% Today
Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 11, 2022 at 4:22 PM.